Related Experiment Video
Updated: Nov 23, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella
Huali Su1,2, Qing Liu1, Xiaoping Bian1
1College of Veterinary Medicine, Southwest University, Chongqing 400715, China.
Insights
This study developed a low-cost live vaccine using recombinant attenuated Salmonella vaccine strains to express Streptococcus pneumoniae capsular polysaccharides. This innovative approach offers a promising strategy for global pneumococcal disease prevention.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Streptococcus pneumoniae capsular polysaccharides (CPSs) are key virulence factors and targets of current pneumococcal vaccines.
- Existing polysaccharide-based vaccines are costly and difficult to produce, limiting their global accessibility.
- There is a need for affordable and effective pneumococcal vaccines, especially for developing countries.
Purpose of the Study:
- To develop a low-cost live vaccine against Streptococcus pneumoniae using a recombinant attenuated Salmonella vaccine (RASV) system.
- To express seven different serotypes of S. pneumoniae CPSs in RASV strains.
- To evaluate the immunogenicity and protective efficacy of the developed RASV-CPS vaccine in a mouse model.
Main Methods:
- Genes encoding seven different S. pneumoniae CPS serotypes were cloned and expressed in an RASV strain.
- Mice were orally immunized with the developed RASV-CPS strains.
- Immune responses, including Th1-biased adaptive immunity and CPS-specific antibody production, were analyzed.
- Opsonophagocytic killing assays were performed in vitro.
- Mice were challenged with virulent S. pneumoniae strains to assess vaccine protection.
Main Results:
- Oral immunization with RASV-CPS strains induced robust Th1-biased adaptive immune responses in mice.
- CPS-specific antisera demonstrated opsonophagocytic killing activity against corresponding S. pneumoniae serotypes in vitro.
- RASV-CPS2 and RASV-CPS3 strains provided significant protection against challenge infections with S. pneumoniae strains D39 and WU2.
- The RASV system successfully synthesized and delivered S. pneumoniae CPSs.
Conclusions:
- The synthesis and delivery of S. pneumoniae CPSs using RASV strains represent an innovative strategy for developing low-cost pneumococcal vaccines.
- This approach holds potential for improved vaccine production and accessibility worldwide.
- The RASV-CPS vaccine platform shows promise for future pneumococcal disease prevention efforts.
Abstract:
Streptococcus pneumoniae capsular polysaccharides (CPSs) are major determinants of bacterial pathogenicity. CPSs of different serotypes form the main components of the pneumococcal vaccines Pneumovax, Prevnar7, and Prevnar13, which substantially reduced the S. pneumoniae disease burden in developed countries. However, the laborious production processes of traditional polysaccharide-based vaccines have raised the cost of the vaccines and limited their impact in developing countries. The aim of this study is to develop a kind of low-cost live vaccine based on using the recombinant attenuated Salmonella vaccine (RASV) system to protect against pneumococcal infections. We cloned genes for seven different serotypes of CPSs to be expressed by the RASV strain. Oral immunization of mice with the RASV-CPS strains elicited robust Th1 biased adaptive immune responses. All the CPS-specific antisera mediated opsonophagocytic killing of the corresponding serotype of S. pneumoniae in vitro. The RASV-CPS2 and RASV-CPS3 strains provided efficient protection of mice against challenge infections with either S. pneumoniae strain D39 or WU2. Synthesis and delivery of S. pneumoniae CPSs using the RASV strains provide an innovative strategy for low-cost pneumococcal vaccine development, production, and use.
Related Concept Videos
Vaccinations
Formation of Lipopolysaccharides
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

